Biotech news
Pharma
As AbbVie’s multibillion-dollar blockbuster drops over the patent cliff, is it time to tighten up patent and pricing strategies in the US? Sarah Speight investigates. 21 March 2023
Biotech
New R&D tax incentive announced for SMEs in UK Budget | Funding for medicines regulator aims to open up drug approvals | ‘Hidden benefits’ in Budget for industry | Reaction from Bioindustry Association, Potter Clarkson, Mischon de Reya, Marks & Clerk, Taylor Wessing. 16 March 2023
Biotech
“Customer suit exception” is rejected by district judge | Suit between Chr. Hansen and Glycosyn is ongoing. 14 March 2023
Biotech
The Pharmaceutical Accountability Foundation has accused the pharma giant of excessively pricing its blockbuster drug, and believes it could influence the regulation of pricing and patent policy for global medicines in the process. 9 March 2023
Biotech
Boehringer Ingelheim challenged university patent | Board must provide more details on ruling. 2 March 2023
Biotech
Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19. 21 February 2023
Asia
The Tokyo District Court judgment on patent infringement and question of territoriality is game-changing, says Takanori Abe of Abe & Partners. 9 February 2023
Biotech
Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas. 19 January 2023
Americas
With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports. 17 January 2023
Biotech
Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth. 12 January 2023